CausalSentinel

Protein Dossier — MSMB (Beta-microseminoprotein)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Cancer code self-reported: prostate cancer -0.277 0.0387 7.81e-13 Wald ratio 1 cis 1
Diagnoses - main ICD10: C61 Malignant neoplasm of prostate -0.282 0.0408 4.75e-12 Wald ratio 1 cis 1
HOMA-B -0.0102 0.00356 0.00427 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hayfever or allergic rhinitis -0.0286 0.0106 0.00696 Wald ratio 1 cis NA
Weight -0.00583 0.00221 0.00836 Wald ratio 1 cis NA
Non-cancer illness code self-reported: mania or bipolar disorder or manic depression -0.15 0.0572 0.00855 Wald ratio 1 cis NA
Alcohol intake frequency -0.0096 0.0037 0.00952 Wald ratio 1 cis NA
Myocardial infarction 0.0257 0.0108 0.018 Wald ratio 1 cis NA
HOMA-IR -0.0101 0.00438 0.0213 Wald ratio 1 cis NA
Non-cancer illness code self-reported: emphysema or chronic bronchitis -0.0519 0.0228 0.0228 Wald ratio 1 cis NA
Iron -0.0238 0.0106 0.0244 Wald ratio 1 cis NA
Coronary heart disease 0.0217 0.00969 0.025 Wald ratio 1 cis NA
…and 104 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

79 association rows across 33 traits (69 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating MSMB levels 7e-5547 rs10993994 2 GCST90860651 no MR -> candidate analysis
Beta-microseminoprotein levels 2e-2145 rs10993994 2 GCST90246712 no MR -> candidate analysis
Beta-microseminoprotein levels (MSMB.10620.21.3) 4e-589 rs10993994 2 GCST90240438 no MR -> candidate analysis
Prostate-specific antigen levels 4e-436 rs10993994 5 GCST90461907 no MR -> candidate analysis
Blood protein levels 1e-329 rs11006489 1 GCST006585 no MR -> candidate analysis
Prostate cancer 1e-325 rs10993994 36 GCST90274713 MR: beta=-0.277, p=7.81e-13 (cis)
MSMB protein levels 1e-101 rs113749034 3 GCST90469949 no MR -> candidate analysis
Cerebrospinal fluid protein MSMB levels 1e-79 rs10993994 1 GCST90944826 no MR -> candidate analysis
PSP94 plasma levels 8e-49 rs10993994 1 GCST90085769 no MR -> candidate analysis
Secretory phospholipase A2 receptor protein levels (SomaScan 7e-38 rs10993994 1 GCST90438883 no MR -> candidate analysis
Circulating CRISP2 levels 2e-17 rs10993994 1 GCST90860530 no MR -> candidate analysis
CRISP2 protein levels 3e-17 rs10993994 1 GCST90468865 no MR -> candidate analysis
…and 21 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 310 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
prostate carcinoma 0.854 common-variant locus no MR -> candidate analysis
prostate cancer 0.802 common-variant locus MR: beta=-0.277, p=7.81e-13 (cis)
ovarian cancer 0.538 common-variant locus MR: beta=0.0214, p=0.187 (cis)
cancer 0.549 common-variant locus MR: beta=-0.277, p=7.81e-13 (cis)
endometrial cancer 0.538 common-variant locus no MR -> candidate analysis
gastric cancer 0.538 common-variant locus no MR -> candidate analysis
non-Hodgkin lymphoma 0.538 common-variant locus no MR -> candidate analysis
breast carcinoma 0.538 common-variant locus no MR -> candidate analysis
lung cancer 0.538 common-variant locus no MR -> candidate analysis
hepatocellular carcinoma 0.538 common-variant locus no MR -> candidate analysis
cervical carcinoma 0.538 common-variant locus no MR -> candidate analysis
biliary tract cancer 0.538 common-variant locus no MR -> candidate analysis
exocrine pancreatic carcinoma 0.538 common-variant locus no MR -> candidate analysis
colorectal cancer 0.538 common-variant locus no MR -> candidate analysis
esophageal cancer 0.538 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 12 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=0.00033, LOEUF=1.62 — LoF-tolerant
GWAS Catalog 43 unique SNPs / 86 rows
ClinVar 91 records; 13 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance